T1	Participants 142 237	polyarteritis nodosa and Churg-Strauss syndrome patients with factors predicting poor prognosis
T2	Participants 274 292	sixty-two patients
T3	Participants 555 566	62 patients
T4	Participants 1023 1098	Patients with hepatitis B virus-related PAN were not included in this study
T5	Participants 348 413	severe polyarteritis nodosa (PAN) and Churg-Strauss syndrome (CSS
T6	Participants 2561 2578	severe PAN or CSS
